Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Isobaric versus hyperbaric intrathecal bupivacaine in elective total knee arthroplasty
2022-000857-10Phase 4Completed
- Sponsor
- Centre Hospitalier Universitaire de Liège
- Start
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of bupivacaine in knee osteoarthritis (OA), postoperative pain and hypotension (2 arms), sponsored by Centre Hospitalier Universitaire de Liège. Primary endpoint: Nadir of mean arterial pressure during first hour after spinal anesthesia. Started Apr 2022; status: completed.
02
Drugs
bupivacaine
03
Conditions
knee osteoarthritis (OA)postoperative painhypotension
Beyond the preview
Go deeper on 2022-000857-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-000857-10.